[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Vita Coco Company, Inc. (COCO) reported insider sales by Martin Roper executed under a Rule 10b5-1 trading plan. The filing shows multiple dispositions of 5,000 shares on 10/03/2025 and 10/06/2025, with reported weighted-average prices around $42.6–$42.9. After the reported sales, Mr. Roper directly beneficially owned 293,897 shares and held indirect interests through family trusts and related parties; several family trusts show remaining indirect holdings in the low- to mid-200,000s.

The form also lists fully vested and exercisable non-qualified stock options and other option grants: a large exercisable option for 579,670 shares at an exercise price of $10.178, plus additional option tranches totaling several hundred thousand shares with exercise prices from $10.178 to $32.78 and various vesting/expiration dates through 2035. The sales were made pursuant to a 10b5-1 plan; the filer offered to provide transaction-level price details on request.

Positive

• Sales executed under a Rule 10b5-1 plan providing pre-established trading parameters
• Reporting person retains significant vested options (e.g., 579,670 shares exercisable at $10.178) indicating ongoing alignment with equity performance
• Willingness to disclose weighted-average price ranges and to provide transaction-level details on request

Negative

• Insider sold a total of 20,000 shares over two dates, which modestly reduces direct holdings
• Large option positions could lead to future dilution if exercised and shares are sold into the market

Insights

Corporate Governance & Insider Transactions Analyst

Insider sold modest stakes under a 10b5-1 plan while retaining large option positions.

The sales reported total 20,000 common shares across 10/03/2025 and 10/06/2025 at weighted-average prices near $42.6–$42.9, executed under a Rule 10b5-1 plan which provides an affirmative defense to insider trading claims when conditions are met. The reporting shows both direct holdings and material indirect holdings through family trusts, preserving substantial economic exposure to company equity.

Remaining option positions are sizable: a fully exercisable option for 579,670 shares at $10.178 plus additional grants summing to several hundred thousand shares with exercise prices up to $32.78 and expirations through 2035. Monitor any future scheduled exercise or sale activity and filings that change outstanding option or trust holdings over the next 12–24 months.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roper Martin

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/03/2025		S(1)		5,000	D	$42.918(2)	293,897	D
Common Stock	10/06/2025		S(1)		5,000	D	$42.671(3)	288,897	D
Common Stock	10/03/2025		S(1)		5,000	D	$42.911(4)	228,406	I	by Chris Roper FT(5)
Common Stock	10/06/2025		S(1)		5,000	D	$42.618(6)	223,406	I	by Chris Roper FT(5)
Common Stock	10/03/2025		S(1)		5,000	D	$42.914(7)	227,515	I	by Peter Roper FT(8)
Common Stock	10/06/2025		S(1)		5,000	D	$42.6(9)	222,515	I	by Peter Roper FT(8)
Common Stock	10/03/2025		S(1)		5,000	D	$42.917(10)	228,531	I	by Thomas Roper FT(11)
Common Stock	10/06/2025		S(1)		5,000	D	$42.51(12)	223,531	I	by Thomas Roper FT(11)
Common Stock								61,200	I	by Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(13)	09/19/2029	Common Stock	579,670		579,670	D
Non-Qualified Stock Option (right to buy)	$10.178							(14)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(15)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(16)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(17)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(18)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.11, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.90 to $43.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

5. These shares are held by the Christopher G. Roper Exempt Family Trust.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.92 to $43.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

8. These shares are held by the Peter S. Roper Exempt Family Trust.

9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.92 to $43.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.52 to $43.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

11. These shares are held by the Thomas L. Roper Exempt Family Trust.

12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.90 to $43.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

13. The stock option is fully vested and currently exercisable.

14. The stock option is fully vested and currently exercisable.

15. The stock option vests in four equal annual installments beginning on November 27, 2022.

16. The stock option vests in four equal annual installments beginning on March 10, 2024.

17. The stock option vests in four equal annual installments beginning on March 4, 2025.

18. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	By: Alison Klein, Attorney-in-Fact For: Martin Roper	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Martin Roper report for COCO?

Martin Roper reported sales of 20,000 common shares executed on 10/03/2025 and 10/06/2025 under a Rule 10b5-1 trading plan at weighted-average prices near $42.6–$42.9.

How many shares does the reporting person own after the transactions?

The filing shows 293,897 shares directly beneficially owned by the reporting person after the reported transactions, plus indirect holdings through family trusts in the low- to mid-200,000s.

Are any stock options exercisable for COCO and how large are they?

Yes. Notably, a fully vested exercisable non-qualified option covers 579,670 shares at an exercise price of $10.178, plus additional options totaling several hundred thousand shares with exercise prices up to $32.78 and expirations through 2035.

Were the sales discretionary or under a trading plan?

The sales were effected pursuant to a Rule 10b5-1 trading plan, as disclosed in the filing.

Does the filing disclose precise per-trade prices?

The filing reports weighted-average prices and disclosed price ranges for the multiple transactions; the filer offered to provide exact per-trade counts and prices to the issuer, security holders, or the SEC upon request.